Sandra Hrometz, Ph.D, BS Pharm., CGP
Visiting Professor of Pharmaceutical And Graduate Life Sciences and Pharmacogenomics
260-470-2714
slhrometz@manchester.edu
Dr. Hrometz joined the faculty in the Pharmacy Program in 2015. Her previous positions were also in academia at Ohio Northern University and the University of Findlay since 2000. She received her BSPharm from Ohio Northern University in 1994 and obtained
her PhD in Pharmacology from the University of Kentucky in 1998. In addition to teaching, Dr. Hrometz has practiced as a part-time pharmacist in retail, hospital and long-term care settings since 1994. In 2012 she obtained certification as a Geriatric
Pharmacist (CGP) through the American Society of Consultant Pharmacists (ASCP).
Areas of interest/recent projects:
My teaching interests include Endocrine, Cardiovascular and Geriatric Pharmacotherapy. Outside areas of service include membership on the Medicaid Pharmacy and Therapeutics Committee for the State of Ohio and membership on the Editorial Board for the
Austin Journal of In Vitro Fertilization (AJIF). Opportunities to work with students outside of the classroom (as part of APPE rotations and writing journal articles/continuing pharmacist education) are openly embraced!
Publications/Presentations/Posters
Journals:
Orlinski H, Stewart H, Lanker A, Kradel S, Hrometz SL. Answers About the Need for Vitamin D Supplementation. Pharmacy and Wellness (PAW) Review,
5(2):26-30, 2014.
Steele J, Ruhe AM, Skouby A, Stack, Hrometz SL. Signifor® Receives FDA Approval for the Management of Cushing's Disease. Pharmacy and Wellness (PAW) Review,
4(2):67-70, 2013.
Tucker TA, Turley S, Bollinger K, Beck J, Hrometz SL. Comparing the GLP-1 Receptor Agonists: Byetta®, Victoza® and once-weekly BydureonTM . Pharmacy and Wellness (PAW) Review,
4(1):16-20, 2013.
Hoersten A, Tucker TA, Steele JW, Meyer A, Hrometz SL. Safety and Efficacy of Human Chorionic Gonadotropin (hCG) in Weight Loss. Pharmacy and Wellness (PAW) Review,
3(1):23-25, 2012.
Hrometz SL. Oral tranexamic acid (Lysteda) for cyclic heavy menstrual bleeding. Ann of Pharmacother, 46(7-8):1047-1053,
2012.
Amero JL, Bauer JL, Webb SM, Fischer RA, Hallman LA, Hrometz SL. An Update on Gestational Diabetes. The Pharmacy and Wellness Review, 2(2):38-41,
2011.
Hrometz SL, Thatcher KE, Ebert JA, Mills EM, Sprague JE Identification of a possible role for atrial natriuretic peptide in MDMA-induced hyperthermia. Tox. Lett.,
206:234-237, 2011.
Hrometz SL, Gates VA. Review of available infertility treatments. Drugs of Today, 45(4):275-291, 2009.
Hrometz SL, Shields KM. Role of Ambrisentan in the Management of Pulmonary Hypertension. Ann of Pharmacother, 42(11):1653-9, 2008.
Hrometz SL, Shields KM. Sildenafil Citrate for Treatment of Pulmonary Hypertension. Drugs of Today, 42(12):771-84, 2006.
Shields KM,
Hrometz SL. Use of Phosphodiesterase Inhibitors for Female Sexual Dysfunction. Ann of Pharmacother, 40(5):931-4, 2005.
Hrometz SL, Brown AW, Nichols D E, Sprague JE. 3-4-Methylenedioxymethamphetamine (MDMA, Ecstasy)-Mediated Production of Hydrogen Peroxide in an In Vitro Model: The Role of
Dopamine, the Serotonin-Reuptake Transporter, and Monoamine Oxidase-B. Neuroscience Lett. 367:56-59, 2004.
Book Chapters:
Hrometz SL. (2014) Topic: Benign Prostate Hypertrophy. In Mason B, Parker D & Lott RS (Eds.), Capstone Pharmacy Review (pp
627-631). Jones & Barlett Learning.
Hrometz SL. (2014) Topic: Glaucoma. In Mason B, Parker D & Lott RS (Eds.), Capstone Pharmacy Review (pp 632-638). Jones & Barlett Learning.
Hrometz SL. (2014) Topic: Urinary Incontinence. In Mason B, Parker D & Lott RS (Eds.), Capstone Pharmacy Review (pp 639-644). Jones & Barlett Learning.
Hrometz SL. (2014)
Topic: Osteoporosis. In Mason B, Parker D & Lott RS (Eds.), Capstone Pharmacy Review (pp 644-650). Jones & Barlett Learning.
Hrometz SL. (2014) Topic: Special Considerations for
the Geriatric Patient. In Mason B, Parker D & Lott RS (Eds.), Capstone Pharmacy Review (pp 650-655). Jones & Barlett Learning.
Written Pharmacist Continuing Education:
Ruhe AM, Muhlenkamp R, Brown A, Blum E, Hrometz SL. Dapagliflozin: a newly-approved SGLT2 inhibitor for the treatment of Type II Diabetes Mellitus. Pharmacy and Wellness (PAW) Review,
5(3):2-9, 2014.
Schoenberger EB, Tucker TA, Steele JW, Meyer A, Hrometz SL. Lysteda for heavy menstrual bleeding. Pharmacy and Wellness (PAW) Review,
3(2):48-53, 2012.
On-line Pharmacist Continuing Education:
Hrometz SL, Tietz L. Vitamin D: Benefits and Recent Changes in Dietary Recommendations
Ohio Northern University - CONTINUING PHARMACY EDUCATION
April, 2011.
Invited Talks:
2014 Invited Lecturer on Male and Female Pathophysiology at Ferris State University’s College of Pharmacy (Big Rapids, MI)
2007 Invited speaker for the Cardinal Health Retail Business Conference (Boston, MA):
1) “Estrogen
Therapy / Menopause / Infertility Treatment: Where are we Now?”
2) “Drug Therapy Management of the Geriatric Patient”
2006 Invited speaker for the Buckeye Association of School Administrators: “Menopause,
Hormone Replacement Therapy and Osteoporosis” (Columbus, OH)
Poster presentations:
Kradel S, Hrometz SL. Exploring the Connection Between Carbohydrates and Alzheimer’s Disease. Poster presented at: Ohio Research Forum. 136th Annual Conference of the Ohio Pharmacists Association; 2014 April 4-6; Columbus, OH.
Thatcher
K, Ebert J, Sprague J, Hrometz S. The Role of Atrial Natriuretic Peptide in MDMA-mediated Thermogenesis. Butler University Undergraduate Research Conference, Indianapolis, IN, May, 2011.
Ebert J, Thatcher K, Sprague J, Hrometz S. MDMA-induced Thermogenesis is Mediated by Fatty Acid Uptake in Skeletal Muscle Sigma Xi Research Presentation, Ada, OH, May, 2010.
Thatcher K, Ebert J, Sprague J, Hrometz S. MDMA-induced Thermogenesis is Attenuated by Atrial Natriuretic Peptide NPR-A Receptor Antagonist Anantin. Sigma Xi Research Presentation, Ada, OH, May, 2010.
Ebert J, Thatcher K, Sprague J, Hrometz S. MDMA-induced Thermogenesis is Mediated by Fatty Acid Uptake in Skeletal Muscle. Posters at the Capitol, Columbus, OH May, 2010.
Thatcher K, Ebert J, Sprague J, Hrometz S. MDMA-induced Thermogenesis is Attenuated by Atrial Natriuretic Peptide NPR-A Receptor Antagonist Anantin. Posters at the Capitol, Columbus, OH May, 2010.
Gehret C, Buzard S, Otte J, Hrometz S, Sprague
J. Attenuated thermogenic response to ecstasy in rodent model of type 2 diabetes. Sigma Xi Research Presentation, Ada, OH, May, 2009.
Thatcher K, Otte J, Ebert J, Sprague J, Hrometz S. Use of 2-NBDG to track glucose uptake as an indicator of energy loss through uncoupling protein-3 (UCP-3): Implications for ecstasy-induced thermogenesis. Sigma Xi Research Presentation, Ada, OH, May,
2009.
Otte J, Gehret C, Buzard S, Hrometz S, Sprague J. Attenuation of Ecstasy-induced Hyperthermia in Animal Models of Type 1 Diabetes. Sigma Xi Research Presentation, Ada, OH, May, 2009.
Otte J, Sprague J, Hrometz S. Measuring cellular glucose
uptake as an indicator of energy loss through uncoupling protein-3 (UCP-3): Implications for ecstasy-induced thermogenesis. Sigma Xi Research Presentation, Ada, OH, April, 2008.
Gehret C, Buzard S, Hrometz S, Sprague J. The effect of rosiglitazone
on ecstasy-induced hyperthermia. Sigma Xi Research Presentation, Ada, OH, April, 2008.
Gehret C, Tietz D, Hairr C, Hrometz S, Sprague J. The role of cAMP in ecstasy-induced hyperthermia. Ohio Northern University Undergraduate Research Colloquium, Ada, OH, April, 2007.
Lizza B, Symmonds P, Hrometz S, Sprague J. (2007, April). Development of an in-vitro model for examining the thermogenic mechanisms of ecstasy. Ohio Northern University Undergraduate Research Colloquium, Ada, OH, April, 2007.